Studies in 2004 had indicated that clobutinol has the potential to prolong the [[QT interval]].<ref name="pmid15280442">{{Cite journal 

 
| last1 = Bellocq | first1 = C. 

 
| last2 = Wilders | first2 = R. 

 
| last3 = Schott | first3 = J. J. 

 
| last4 = Louérat-Oriou | first4 = B. 

 
| last5 = Boisseau | first5 = P. 

 
| last6 = Le Marec | first6 = H. 

 
| last7 = Escande | first7 = D. 

 
| last8 = Baró | first8 = I. 

 
| doi = 10.1124/mol.104.001065 

 
| title = A Common Antitussive Drug, Clobutinol, Precipitates the Long QT Syndrome 2 

 
| journal = Molecular Pharmacology 

 
| volume = 66 

 
| issue = 5 

 
| pages = 1093–1102 

 
| year = 2004 

 
| pmid = 15280442 

 
| pmc = 

 
}}</ref>

 
Clobutinol was in 2007 determined to cause [[cardiac arrhythmia]] in some patients.<ref>

 
{{ cite web 

 
| url = http://www.bfarm.de/DE/BfArM/Presse/mitteil2007/pm20-2007.html 

 
| title = Clobutinol-haltige Arzneimittel: BfArM ordnet Widerruf der Zulassung an. 

 
| publisher = BfArM (German Federal Institute for Drugs and Medical Devices) 

 
| date = 2007-08-31 

 
| quote = Clobutinol: BfArM orders cancellation of approval 

 
| deadurl = yes 

 
| archiveurl = https://web.archive.org/web/20120401035256/http://www.bfarm.de/DE/BfArM/Presse/mitteil2007/pm20-2007.html 

 
| archivedate = 2012-04-01 

 
| df =  

 
}}</ref>

 


 
[[Boehringer Ingelheim]] products containing clobutinol were voluntarily withdrawn from sale in [[Germany]], and the rest of the world, on August 31, 2007.<ref>

 
{{ cite web 

 
| url = http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2007/31_august_2007.html 

 
| publisher = Boehringer Ingelheim 

 
| date = 2007-08-31 

 
| title = Boehringer Ingelheim voluntarily withdraws its clobutinol containing medications. 

 
| deadurl = yes 

 
| archiveurl = https://web.archive.org/web/20120127070831/http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2007/31_august_2007.html 

 
| archivedate = 2012-01-27 

 
| df =  

 
}}</ref>

 


 
The approval for Germany and the EU was revoked in 2008.<ref>

 
{{ cite web 

 
| title = Cancellation of approval 

 
| url = http://www.bfarm.de/SharedDocs/1_Downloads/DE/Pharmakovigilanz/stufenplverf/globutinol_bescheid_080613.pdf?__blob=publicationFile 

 
| format = pdf 

 
| quote = Die Zulassungen für die o.g. Arzneimittel werden mit sofortiger Wirkung widerrufen. 

 
| publisher = BfArM (German Federal Institute for Drugs and Medical Devices) 

 
| date = 2008-06-06 

 
| deadurl = yes 

 
| archiveurl = https://web.archive.org/web/20120401034947/http://www.bfarm.de/SharedDocs/1_Downloads/DE/Pharmakovigilanz/stufenplverf/globutinol_bescheid_080613.pdf?__blob=publicationFile 

 
| archivedate = 2012-04-01 

 
| df =  

 
}}</ref>

 

